Shanghai RAAS Blood Products Dividends and Buybacks
Dividend criteria checks 3/6
Shanghai RAAS Blood Products is a dividend paying company with a current yield of 0.5% that is well covered by earnings.
Key information
0.5%
Dividend yield
1.8%
Buyback Yield
| Total Shareholder Yield | 2.3% |
| Future Dividend Yield | 0.2% |
| Dividend Growth | 18.4% |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | CN¥0.037 |
| Payout ratio | 24% |
Recent dividend and buyback updates
Recent updates
Stability and Growth of Payments
Fetching dividends data
Stable Dividend: 002252's dividend payments have been volatile in the past 10 years.
Growing Dividend: 002252's dividend payments have increased over the past 10 years.
Dividend Yield vs Market
| Shanghai RAAS Blood Products Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (002252) | 0.5% |
| Market Bottom 25% (CN) | 0.6% |
| Market Top 25% (CN) | 2.2% |
| Industry Average (Biotechs) | 1.2% |
| Analyst forecast (002252) (up to 3 years) | 0.2% |
Notable Dividend: 002252's dividend (0.5%) isn’t notable compared to the bottom 25% of dividend payers in the CN market (0.55%).
High Dividend: 002252's dividend (0.5%) is low compared to the top 25% of dividend payers in the CN market (2.17%).
Earnings Payout to Shareholders
Earnings Coverage: With its low payout ratio (24.3%), 002252's dividend payments are well covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: With its reasonable cash payout ratio (54.9%), 002252's dividend payments are covered by cash flows.